Expanded criteria for hepatocellular carcinoma: Down-staging with a view to liver transplantation - Yes

被引:32
作者
Yao, Francis Y. [1 ]
机构
[1] Univ Calif San Francisco, San Francisco, CA 94143 USA
关键词
hepatocellular carcinoma; orthotopic liver transplantation; Milan criteria; down-staging; University of California San Francisco criteria;
D O I
10.1055/s-2006-947295
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
In patients with hepatocellular carcinoma (HCC) exceeding conventional Milan criteria (one lesion <= 5 cm or two or three lesions <= 3 cm) for orthotopic liver transplantation (OLT), down-staging of the tumor before OLT presents an unique and intriguing perspective on tumor biology and expanded criteria for OLT. According to the University of California, San Francisco protocol, the eligibility criteria for down-staging included one lesion <= 8 cm, two or three lesions each <= 5 cm with total tumor diameter <= 8 cm, or four or five lesions each <= 3 cm with total tumor diameter <= 8 cm. In the majority of these patients, successful down-staging using well-defined endpoints could be achieved prior to OLT, without resulting in post-transplantation HCC recurrence. The promise of down-staging warrants consideration of a unified policy granting patients with HCC that has been successfully down-staged the same priority listing for OLT as those meeting conventional criteria.
引用
收藏
页码:239 / 247
页数:9
相关论文
共 44 条
[1]   Liver transplantation for hepatocellular carcinoma [J].
Befeler, AS ;
Hayashi, PH ;
Di Bisceglie, AM .
GASTROENTEROLOGY, 2005, 128 (06) :1752-1764
[2]   Should we expand the criteria for liver transplantation for hepatocellular carcinoma - Yes, of course! [J].
Broelsch, CE ;
Frilling, A ;
Malago, M .
JOURNAL OF HEPATOLOGY, 2005, 43 (04) :569-573
[3]   Liver transplantation for hepatocellular carcinoma: foucault pendulum versus evidence-based decision [J].
Bruix, J ;
Fuster, J ;
Llovet, JM .
LIVER TRANSPLANTATION, 2003, 9 (07) :700-702
[4]   Prognostic prediction and treatment strategy in hepatocellular carcinoma [J].
Bruix, J ;
Llovet, JM .
HEPATOLOGY, 2002, 35 (03) :519-524
[5]   Liver transplantation for the treatment of moderately or well-differentiated hepatocellular carcinoma [J].
Cillo, U ;
Vitale, A ;
Bassanello, M ;
Boccagni, P ;
Brolese, A ;
Zanus, G ;
Burra, P ;
Fagiuoli, S ;
Farinati, F ;
Rugge, M ;
D'Amico, DF .
ANNALS OF SURGERY, 2004, 239 (02) :150-159
[6]   Liver transplantation for hepatocellular cancer: should the current indication criteria be changed? [J].
De Carlis, L ;
Giacomoni, A ;
Lauterio, A ;
Slim, A ;
Sammartino, C ;
Pirotta, V ;
Colella, G ;
Forti, D .
TRANSPLANT INTERNATIONAL, 2003, 16 (02) :115-122
[7]  
Decaens T, 2004, HEPATOLOGY, V40, p550A
[8]   Hepatocellular carcinoma: Recent trends in the United States [J].
El-Serag, HB .
GASTROENTEROLOGY, 2004, 127 (05) :S27-S34
[9]  
Eng Sue C, 2002, Gastroenterology, V122, P579, DOI 10.1016/S0016-5085(02)80327-4
[10]   Chemoembolization followed by liver transplantation for hepatocellular carcinoma impedes tumor progression while on the waiting list and leads to excellent outcome [J].
Graziadei, IW ;
Sandmueller, H ;
Waldenberger, P ;
Koenigsrainer, A ;
Nachbaur, K ;
Jaschke, W ;
Margreiter, R ;
Vogel, W .
LIVER TRANSPLANTATION, 2003, 9 (06) :557-563